+44 1223 790975
Institute for Glycomics
Griffith University, Australia
Dr.Julie Webster pursued her phd in Ph.Din University of Queensland 2017 on Characterisation of the glycosylation pathway required for the post-translational modification of adiponectin.Followed by Bachelor of Science (Honours) in James Cook University, 2004 on Biochemistry and Molecular Biology . In 2013 she was a Senior Research Assistant, Mater Medical Research Institute.Senior Research Assistant/Laboratory Manager, Mater Medical Research Institute 2007 to 2009, Laboratory Manager/Compliance Officer, Diamantina Institute for Cancer, Immunology and Metabolic Medicine.Research Assistant, Diamantina Institute for Cancer, Immunology and Metabolic Medicine during 2006 to 2007.2005 to 2006, Research Assistant, James Cook University.
Dr. Julie Webster has primarily focused on molecular mechanisms of disease. she has worked across a number of fields ranging from neuroscience, to immunology, metabolism and infectious disease.She has a special interest in post-translational modifications including enzymatic and non-enzymatic glycosylation. She investigated this area in Alzheimer’s Disease, specifically investigating advanced glycation endproducts (AGEs), examining the immune response induced by various types of AGEs. She has furthered this interest in relation to obesity and Type 2 Diabetes where she investigated post-translational modifications on the anti-inflammatory and insulin sensitizing molecule, adiponectin. This has included examining sialylation and glycosylation. During PhD,She characterized the molecular pathway involved in the glycosylation of adiponectin. Not only is protein glycosylation important for Diabetes and Alzheimer’s Disease, but it is also critical in recognition of infectious organisms.Now conducting research in the area of infectious diseases, specifically investigating the effects of arthritis that is caused by Ross River virus.